With the rising adoption of checkpoint inhibitors and combination therapies, BAVENCIO’s market growth is driven by expanding indications and strategic…
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) — Prospect Capital Management L.P. (“Prospect”), investment adviser to Prospect Capital Corporation (NASDAQ:…